Divided or Single Exposure (DOSE) Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Divided or Single Exposure (DOSE) Study — Stella

Home/Opioid Use Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Opioid Use Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Addiction Treatment Services (ATS), Baltimore, Maryland

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

University of Maryland, Baltimore

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~150 participants

Started

February 2023

Primary completion

June 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 100 Years

Last updated February 2026